Cargando…
A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury
Autores principales: | Memon, Aliza A., Ahmed, Hasban, Li, Yi, Wongboonsin, Janewit, Hundert, Joshua, Benoit, Stefanie, Chaudhari, Advika, Sher, Jawad, Ghimire, Pratima, Hopkins, Rebecca, Patel, Jay, Stegman, Melinda, Lim, Kenneth, Azzi, Jamil, Siedlecki, Andrew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465494/ https://www.ncbi.nlm.nih.gov/pubmed/36120390 http://dx.doi.org/10.1016/j.ekir.2022.09.003 |
Ejemplares similares
-
Ravulizumab for paroxysmal nocturnal haemoglobinuria
Publicado: (2022) -
Acetazolamide Therapy in Patients with Heart Failure: A Meta-Analysis
por: Wongboonsin, Janewit, et al.
Publicado: (2019) -
Osmotic Tubulopathy in a Patient With COVID-19 Treated With Remdesivir
por: Wongboonsin, Janewit, et al.
Publicado: (2021) -
Ravulizumab: Lack of efficacy: case report
Publicado: (2022) -
Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)